News Releases Year: - Any -20192018201720162015201420132012 Items per page 102550 01/02/19 Summary ToggleClearside Biomedical to Present at the 37th Annual J.P. Morgan Healthcare Conference PDF Version 12/19/18 Summary ToggleClearside Biomedical Submits New Drug Application for XIPERE™ for the Treatment of Macular Edema Associated with Uveitis PDF Version 11/08/18 Summary ToggleClearside Biomedical Announces Third Quarter 2018 Financial Results and Provides Corporate Update PDF Version 11/07/18 Summary ToggleClearside Biomedical to Participate in Stifel 2018 Healthcare Conference PDF Version 11/05/18 Summary ToggleClearside Biomedical to Report Third Quarter 2018 Financial Results on Thursday, November 8, 2018 – Conference Call to Follow PDF Version 11/05/18 Summary ToggleClearside Biomedical Announces SAPPHIRE Phase 3 Study of Combination Therapy in Retinal Vein Occlusion Did Not Meet Its Primary Endpoint PDF Version 10/29/18 Summary TogglePresentation of Additional Analyses of Clearside’s PEACHTREE Clinical Trial Data Further Supports Potential of XIPERE™ in Treating Uveitic Macular Edema PDF Version 10/25/18 Summary ToggleClearside Biomedical Appoints Thomas A. Ciulla, M.D., MBA as Chief Medical Officer PDF Version 10/22/18 Summary ToggleCLEARSIDE, XIPERE™ and PEACHTREE to be Front and Center at AAO 2018 PDF Version 10/19/18 Summary ToggleClearside Biomedical Appoints Veteran Supply Chain Executive, Thomas Crawford, as Vice President, Supply Chain PDF Version Pagination First page First Previous page Page 2 Current page 3 Page 4 Page 5 Next page Last page Last
